• Profile
Close

Hepatocyte growth factor in blood and gastric cancer risk: A nested case–control study

Cancer Epidemiology, Biomarkers & Prevention Jan 10, 2020

Jang J, et al. - By performing this nested case–control study with 238 gastric cancer cases and 238 matched controls within the Korean Multicenter Cancer Cohort, researchers determined whether gastric cancer development can be predicted by hepatocyte growth factor (HGF)–stimulating signaling pathways related to cytotoxin-associated gene A (CagA). For highest quartile HGF (≥ 364 pg/mL) vs lowest quartile HGF (< 167 pg/mL), they found a sequential rise of gastric cancer risk according to HGF level increase. They also identified that high HGF level measured even 6 or more years before cancer diagnosis was related to a significantly increased gastric cancer risk. The highest gastric cancer risk was observed in relation to the group with both high risk of HGF and CagA-related genetic variants vs the group with both low risk of HGF and genetic variants. Overall, HGF was suggested as a potential biomarker to foretell gastric cancer development.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay